These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 3088346)

  • 21. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon.
    Piéboji JG; Koulla-Shiro S; Ngassam P; Adiogo D; Njine T; Ndumbe P
    Int J Infect Dis; 2004 May; 8(3):147-54. PubMed ID: 15109589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China].
    Chen MJ; Wang H;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):375-81. PubMed ID: 12820912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activities of 'new' and 'conventional' antibiotics against multi-drug resistant Gram negative bacteria from patients in the intensive care unit.
    Ratnam I; Franklin C; Spelman DW
    Pathology; 2007 Dec; 39(6):586-8. PubMed ID: 18027263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic activity of amikacin with aztreonam against Pseudomonas aeruginosa and other gram-negative organisms.
    Greenberg RN; Bollinger M; Compton J
    Clin Ther; 1986; 8(3):354-8. PubMed ID: 3087621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative activity of ceftizoxime against aminoglycoside-resistant aerobic gram-negative bacilli.
    Gómez-Lus R; Rubio MC; García C; Gómez-Lus ML; Alejandre MC
    Drugs Exp Clin Res; 1987; 13(3):155-9. PubMed ID: 3497792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Distribution and drug-resistance of 3 500 gram-negative bacteria in Guangzhou].
    Xiao QZ; Su DH; Jiang JH; Zhong NS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):132-8. PubMed ID: 15698988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ferric ammonium citrate decomposition--a taxonomic tool for gram-negative bacteria.
    Szentmihályi A; Lányi B
    Acta Microbiol Hung; 1986; 33(1):85-95. PubMed ID: 3529797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of aztreonam--a new monocyclic beta-lactam antibiotic.
    Friis H
    Dan Med Bull; 1985 Jun; 32(3):196-8. PubMed ID: 4040456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity and beta-lactamase stability of a new penem, CGP 31608.
    Neu HC; Chin NX; Neu NM
    Antimicrob Agents Chemother; 1987 Apr; 31(4):558-69. PubMed ID: 3496845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative in vitro activity of 5 semi-synthetic penicillins against aerobic Gram-negative bacilli and enterococci (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):318-23. PubMed ID: 6460967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa.
    Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P
    Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Characteristics of the antibiotic sensitivity of nitrofuran--resistant Gram-negative bacteria of clinical origin].
    Shenderov BA; Olenina NA
    Antibiotiki; 1979 Feb; 24(2):106-9. PubMed ID: 434799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Carbenicillin resistance of gram-negative bacteria: incidence, biochemical and genetic determinism].
    Shaokat S; Joly B; Philippon A; Sirot D; Cluzel R
    Pathol Biol (Paris); 1985 Oct; 33(8):825-9. PubMed ID: 3903620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibacterial effect of imipenem in vitro against important aerobic and anaerobic strains isolated from clinical specimens.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Aug; 6(4):243-50. PubMed ID: 3477332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antibacterial activity of aztreonam against clinical isolates].
    Igari J
    Jpn J Antibiot; 1994 May; 47(5):502-20. PubMed ID: 8051793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Susceptibility of clinical isolates to aztreonam].
    Nagasawa Z; Nishimura T; Nagumo F; Ueda H; Tadano J; Katoh O; Yamada H
    Jpn J Antibiot; 1989 Jun; 42(6):1257-70. PubMed ID: 2507799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Yearly changes in antibacterial activities of cefozopran against various clinical isolates between 1996 and 2001--II. Gram-negative bacteria].
    Suzuki Y; Nishinari C; Endo H; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2003 Aug; 56(4):309-35. PubMed ID: 14567255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
    Deguchi K; Oda S; Sato Y; Ikeda Y; Nakamura T
    Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of enteric bacteria in childhood urinary tract infections and their in vitro response to antimicrobial agents].
    Günalp A
    Mikrobiyol Bul; 1979 Jan; 13(1):13-25. PubMed ID: 555789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
    Rubinstein E; Mark Z; Samra Y; Alkan M; Berger S
    Chemioterapia; 1986 Apr; 5(2):75-82. PubMed ID: 2939966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.